<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Whos_Who</title><link>https://investorshangout.com/profile/view?id=14141</link><description><![CDATA[Whos_Who]]></description><language>en-us</language><pubDate>Tue, 03 Nov 2026 21:51:48 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/profile/view?id=14141" rel="self" type="application/rss+xml"/><item><title>Whos_Who: Q BioMed&#039;s Diagnostic Kit Designed to Serve Unmet</title><link>https://investorshangout.com/post/view?id=5387391</link><guid>https://investorshangout.com/post/view?id=5387391</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 21 Mar 2019 16:11:55 GMT</pubDate></item><item><title>Whos_Who: Uphill trend has started! Golden Cross about to</title><link>https://investorshangout.com/post/view?id=5010241</link><guid>https://investorshangout.com/post/view?id=5010241</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 19 Apr 2018 02:46:17 GMT</pubDate></item><item><title>Whos_Who: How about the bigger picture? The company is</title><link>https://investorshangout.com/post/view?id=4963977</link><guid>https://investorshangout.com/post/view?id=4963977</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Sat, 10 Mar 2018 05:03:13 GMT</pubDate></item><item><title>Whos_Who:  Summer AAD Panel to Discuss BPX-01 for Acne and</title><link>https://investorshangout.com/post/view?id=4676651</link><guid>https://investorshangout.com/post/view?id=4676651</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 27 Jul 2017 13:50:47 GMT</pubDate></item><item><title>Whos_Who:  to Present Phase 2b Clinical Trial Acne Data at</title><link>https://investorshangout.com/post/view?id=4620229</link><guid>https://investorshangout.com/post/view?id=4620229</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 22 Jun 2017 13:24:25 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to Report First Quarter Financial</title><link>https://investorshangout.com/post/view?id=4593187</link><guid>https://investorshangout.com/post/view?id=4593187</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 07 Jun 2017 12:48:02 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Advances BPX-01 2% Upon Achieving</title><link>https://investorshangout.com/post/view?id=4582574</link><guid>https://investorshangout.com/post/view?id=4582574</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 01 Jun 2017 13:09:02 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Completes Last Subject Visit in its</title><link>https://investorshangout.com/post/view?id=4495337</link><guid>https://investorshangout.com/post/view?id=4495337</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 20 Apr 2017 13:39:28 GMT</pubDate></item><item><title>Whos_Who: Mmmm.... That new board smell. Thanks for setting</title><link>https://investorshangout.com/post/view?id=4490647</link><guid>https://investorshangout.com/post/view?id=4490647</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 18 Apr 2017 21:45:41 GMT</pubDate></item><item><title>Whos_Who: BioPharmX AACR Poster Will Present Findings</title><link>https://investorshangout.com/post/view?id=4449048</link><guid>https://investorshangout.com/post/view?id=4449048</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 30 Mar 2017 13:21:49 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Invited to Present at 27th Annual</title><link>https://investorshangout.com/post/view?id=4427833</link><guid>https://investorshangout.com/post/view?id=4427833</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 21 Mar 2017 13:49:11 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to Report Fourth Quarter and Full Year</title><link>https://investorshangout.com/post/view?id=4417519</link><guid>https://investorshangout.com/post/view?id=4417519</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 16 Mar 2017 13:22:51 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Society of Toxicology Poster Suggests</title><link>https://investorshangout.com/post/view?id=4409049</link><guid>https://investorshangout.com/post/view?id=4409049</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 13 Mar 2017 13:51:58 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to Present at 29th Annual ROTH</title><link>https://investorshangout.com/post/view?id=4401934</link><guid>https://investorshangout.com/post/view?id=4401934</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 09 Mar 2017 14:32:31 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Presents Poster at American Academy of</title><link>https://investorshangout.com/post/view?id=4387271</link><guid>https://investorshangout.com/post/view?id=4387271</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 02 Mar 2017 14:19:33 GMT</pubDate></item><item><title>Whos_Who: SPIE Photonics West Presentations to Show</title><link>https://investorshangout.com/post/view?id=4314297</link><guid>https://investorshangout.com/post/view?id=4314297</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 26 Jan 2017 14:21:47 GMT</pubDate></item><item><title>Whos_Who: Specialty Pharma Industry Veteran Charles Gregory</title><link>https://investorshangout.com/post/view?id=4305458</link><guid>https://investorshangout.com/post/view?id=4305458</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 23 Jan 2017 14:35:08 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Data Suggest Anti-Inflammatory Activity</title><link>https://investorshangout.com/post/view?id=4285987</link><guid>https://investorshangout.com/post/view?id=4285987</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 12 Jan 2017 14:43:45 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Completes Enrollment of BPX-01 Phase 2b</title><link>https://investorshangout.com/post/view?id=4269085</link><guid>https://investorshangout.com/post/view?id=4269085</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 04 Jan 2017 14:39:05 GMT</pubDate></item><item><title>Whos_Who: RESEARCH REPORT UPDATE BIOPHARMX (BPMX) EXITED</title><link>https://investorshangout.com/post/view?id=4234224</link><guid>https://investorshangout.com/post/view?id=4234224</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 19 Dec 2016 01:32:13 GMT</pubDate></item><item><title>Whos_Who: &quot;The new financing immediately boosted the</title><link>https://investorshangout.com/post/view?id=4234220</link><guid>https://investorshangout.com/post/view?id=4234220</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 19 Dec 2016 01:28:08 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Corporation Reports Third Quarter</title><link>https://investorshangout.com/post/view?id=4222989</link><guid>https://investorshangout.com/post/view?id=4222989</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 13 Dec 2016 21:10:14 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to present evidence that BPX-01 topical</title><link>https://investorshangout.com/post/view?id=4210392</link><guid>https://investorshangout.com/post/view?id=4210392</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 07 Dec 2016 14:31:54 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to Report Third Quarter Financial</title><link>https://investorshangout.com/post/view?id=4207668</link><guid>https://investorshangout.com/post/view?id=4207668</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 06 Dec 2016 14:43:18 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Presents Research at Cell Biology 2016</title><link>https://investorshangout.com/post/view?id=4204557</link><guid>https://investorshangout.com/post/view?id=4204557</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 05 Dec 2016 14:30:34 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Poster at ASCB Annual Meeting to Show</title><link>https://investorshangout.com/post/view?id=4198763</link><guid>https://investorshangout.com/post/view?id=4198763</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 01 Dec 2016 14:13:57 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Corporation Announces Closing of a</title><link>https://investorshangout.com/post/view?id=4192481</link><guid>https://investorshangout.com/post/view?id=4192481</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 28 Nov 2016 22:12:42 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Presents BPX-01 Topical Minocycline Gel</title><link>https://investorshangout.com/post/view?id=4163199</link><guid>https://investorshangout.com/post/view?id=4163199</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 10 Nov 2016 14:09:08 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Still On Track To Be &quot;The Big One&quot; How</title><link>https://investorshangout.com/post/view?id=4141166</link><guid>https://investorshangout.com/post/view?id=4141166</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 26 Oct 2016 21:51:30 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Studies Suggest its Violet® Iodine</title><link>https://investorshangout.com/post/view?id=4139460</link><guid>https://investorshangout.com/post/view?id=4139460</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 26 Oct 2016 13:20:10 GMT</pubDate></item><item><title>Whos_Who: Craig Barbarosh Resins On October 5, 2016, Craig</title><link>https://investorshangout.com/post/view?id=4102317</link><guid>https://investorshangout.com/post/view?id=4102317</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 07 Oct 2016 22:17:40 GMT</pubDate></item><item><title>Whos_Who: BioPharmX (BPMX) Enters 1.55M Share Stock Sales</title><link>https://investorshangout.com/post/view?id=4082375</link><guid>https://investorshangout.com/post/view?id=4082375</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 27 Sep 2016 21:14:10 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Announces Registered Direct Offering</title><link>https://investorshangout.com/post/view?id=4077950</link><guid>https://investorshangout.com/post/view?id=4077950</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 26 Sep 2016 13:58:09 GMT</pubDate></item><item><title>Whos_Who: RESEARCH REPORT UPDATE BIOPHARMX (BPMX) REPORTS</title><link>https://investorshangout.com/post/view?id=4054603</link><guid>https://investorshangout.com/post/view?id=4054603</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 16 Sep 2016 16:59:18 GMT</pubDate></item><item><title>Whos_Who: I&#039;m still excited in that glimpse we had into the</title><link>https://investorshangout.com/post/view?id=4053566</link><guid>https://investorshangout.com/post/view?id=4053566</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 16 Sep 2016 02:55:01 GMT</pubDate></item><item><title>Whos_Who: At $50.00 your math is exaggerated X4+, but you</title><link>https://investorshangout.com/post/view?id=4048581</link><guid>https://investorshangout.com/post/view?id=4048581</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 14 Sep 2016 00:57:47 GMT</pubDate></item><item><title>Whos_Who: Second Quarter Financial Results (Q2 EPS of</title><link>https://investorshangout.com/post/view?id=4045735</link><guid>https://investorshangout.com/post/view?id=4045735</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 13 Sep 2016 02:15:04 GMT</pubDate></item><item><title>Whos_Who:  http://www.tesla-digital.ca</title><link>https://investorshangout.com/post/view?id=4045685</link><guid>https://investorshangout.com/post/view?id=4045685</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 13 Sep 2016 00:51:08 GMT</pubDate></item><item><title>Whos_Who: CEN BIOTECH ANNOUNCES ACQUISITON OF COLD LIGHT</title><link>https://investorshangout.com/post/view?id=4045683</link><guid>https://investorshangout.com/post/view?id=4045683</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Tue, 13 Sep 2016 00:47:59 GMT</pubDate></item><item><title>Whos_Who: BioPharmX to Report Second Quarter Financial</title><link>https://investorshangout.com/post/view?id=4021390</link><guid>https://investorshangout.com/post/view?id=4021390</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 02 Sep 2016 12:05:06 GMT</pubDate></item><item><title>Whos_Who: Awesome news! Thanks for</title><link>https://investorshangout.com/post/view?id=4016914</link><guid>https://investorshangout.com/post/view?id=4016914</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 31 Aug 2016 23:40:13 GMT</pubDate></item><item><title>Whos_Who: Good article here...</title><link>https://investorshangout.com/post/view?id=4006723</link><guid>https://investorshangout.com/post/view?id=4006723</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 26 Aug 2016 17:21:01 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Enrolls First Subject in OPAL Phase 2b</title><link>https://investorshangout.com/post/view?id=4000643</link><guid>https://investorshangout.com/post/view?id=4000643</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Wed, 24 Aug 2016 12:05:49 GMT</pubDate></item><item><title>Whos_Who: BioPharmX Announces Final Phase 2a Trial Results</title><link>https://investorshangout.com/post/view?id=3995013</link><guid>https://investorshangout.com/post/view?id=3995013</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 22 Aug 2016 14:02:48 GMT</pubDate></item><item><title>Whos_Who: Interesting that there is still a strong concern</title><link>https://investorshangout.com/post/view?id=3976803</link><guid>https://investorshangout.com/post/view?id=3976803</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Sun, 14 Aug 2016 17:29:23 GMT</pubDate></item><item><title>Whos_Who: I am by no means a lawyer, but was poking around</title><link>https://investorshangout.com/post/view?id=3975472</link><guid>https://investorshangout.com/post/view?id=3975472</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Sat, 13 Aug 2016 01:43:24 GMT</pubDate></item><item><title>Whos_Who: I&#039;m going to go with hemp seed. Hell, we already</title><link>https://investorshangout.com/post/view?id=3973682</link><guid>https://investorshangout.com/post/view?id=3973682</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Fri, 12 Aug 2016 14:40:17 GMT</pubDate></item><item><title>Whos_Who: Great post! Wish I could 10X thumbs up</title><link>https://investorshangout.com/post/view?id=3970210</link><guid>https://investorshangout.com/post/view?id=3970210</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 11 Aug 2016 02:09:11 GMT</pubDate></item><item><title>Whos_Who: My favorite part of the OMB Pre-Hearing</title><link>https://investorshangout.com/post/view?id=3964339</link><guid>https://investorshangout.com/post/view?id=3964339</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Mon, 08 Aug 2016 21:05:33 GMT</pubDate></item><item><title>Whos_Who: Bill actually responded with an 8-K if you follow</title><link>https://investorshangout.com/post/view?id=3957221</link><guid>https://investorshangout.com/post/view?id=3957221</guid><description><![CDATA[Whos_Who
]]></description><pubDate>Thu, 04 Aug 2016 23:51:15 GMT</pubDate></item></channel></rss>